Cargando…
ABO non-O type as a risk factor for thrombosis in patients with pancreatic cancer
ABO blood type has previously been identified as a risk factor for thrombosis and pancreatic cancer (PC). The aim of the study is to demonstrate the associations between ABO blood type and other clinical factors with the risk of thromboembolism (TE) in patients with PC. We conducted a retrospective...
Autores principales: | Li, Donghui, Pise, Mayurika N, Overman, Michael J, Liu, Chang, Tang, Hongwei, Vadhan-Raj, Saroj, Abbruzzese, James L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673991/ https://www.ncbi.nlm.nih.gov/pubmed/26275671 http://dx.doi.org/10.1002/cam4.513 |
Ejemplares similares
-
Rivaroxaban thromboprophylaxis in ambulatory patients with pancreatic cancer: Results from a pre‐specified subgroup analysis of the randomized CASSINI study
por: Vadhan‐Raj, Saroj, et al.
Publicado: (2020) -
Associations between ABO blood groups and pancreatic ductal adenocarcinoma: influence on resection status and survival
por: El Jellas, Khadija, et al.
Publicado: (2017) -
Association of diabetes and perineural invasion in pancreatic cancer
por: Sahin, Ibrahim Halil, et al.
Publicado: (2012) -
Modified gemcitabine plus nab‐paclitaxel regimen in advanced pancreatic ductal adenocarcinoma
por: Rogers, Jane E., et al.
Publicado: (2020) -
Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patients
por: Mohindroo, Chirayu, et al.
Publicado: (2021)